Ondansetron

Basic Ondansetron Information

• INN (International Nonproprietary Name): Metformin

  **Brand Names (Global Examples, With Packaging):** | Country | Brand Name(s) | Common Packaging & Details | |——————|—————————-|—————————————————————-| | USA/Canada | Glucophage, Glumetza, Riomet| Tablets (500mg, 850mg, 1000mg); Oral solution (500mg/5mL) | | UK/Ireland | Glucophage, Sukkarto, Bolamyn | Film-coated tablets; Slow-release tablets (500mg, 1000mg) | | France | Stagid, Glucophage | Tablets (500mg, 850mg, 1000mg) | | Germany/Austria | Glucophage, Metformin AL | Tablets (500mg, 850mg, 1000mg), Prolonged-release forms | | Eastern Europe | Siofor, Metfogamma | Tablets (500mg, 850mg, 1000mg); Blister packs | | India | Glyciphage, Obimet, Bigomet| Tablets (500mg, 850mg, 1000mg) | | China | Glucophage, Metformin | Tablets; regional generic packaging | | Russia | Siofor, Formetin | Tablets (varied strengths) | | Latin America | Glafornil, Dabex | Tablets 500mg, 850mg, 1000mg |

  **ATC Code and Classification:** – **A10BA02** — This code specifies plain metformin within the ATC hierarchy: – **A:** Alimentary tract and metabolism – **A10:** Drugs used in diabetes – **A10B:** Blood glucose lowering drugs, excl. insulins – **A10BA:** Biguanides – **A10BA02:** Metformin.

  **Pharmaceutical Forms & Dosages:** | Form | Dosages (Strengths) | Notes | |————————|—————————————|——————————————| | Immediate-release tab. | 500mg, 850mg, 1000mg | Standard oral tablets | | Extended-release tab. | 500mg, 750mg, 1000mg | Prolonged/sustained release | | Oral solution/susp. | 500mg/5mL | Suitable for pediatric use |

  **Manufacturers and Suppliers:** – **Global:** Merck Sante, Teva, Novartis (Sandoz), Sun Pharma, Sanofi, Bristol-Myers Squibb – **Local Generics:** Varies per country – **E-shop/Pharmacy Names:** Various generics under “metformin”.

  **Regulatory Status (Examples):** – **EMA (Europe):** Authorized. – **FDA (USA):** Approved for type 2 diabetes.

  **Classification:** – **Prescription Only (Rx):** Globally; NOT available OTC.

  **Standard Dosages & Typical Regimens:** – Start 500mg once daily with food and titrate. – Max typical dose 2000–2550mg/day in divided doses.

  **Absolute Contraindications:** – eGFR <30 mL/min/1.73m². – Severe hepatic impairment. – Acute or chronic metabolic acidosis. – Known hypersensitivity to metformin.

  **Storage & Transport Guidelines:** – Store below 25°C. – Protect from moisture and light.

**Manufacturers In United Kingdom:** – Local generics and international suppliers such as Sandoz and other manufacturers supply metformin preparations in the UK.

**Registration Status In United Kingdom:** – Authorized via EMA/UK regulator listings; commonly prescribed across primary and secondary care.

**OTC / Rx Classification:** – Prescription Only Medicine (POM) in the UK; not available over the counter.

**Manufacturers In United Kingdom:** – Global and local generics supply metformin to UK pharmacies.

**Registration Status In United Kingdom:** – Listed and used widely for type 2 diabetes management.

**OTC / Rx Classification:** – Prescription Only; pharmacy supply requires a valid prescription.

There is a risk of serotonin syndrome when ondansetron is combined with SSRIs, SNRIs, MAOIs or triptans.

MHRA guidance emphasises caution in pregnancy; pregnant patients must discuss risks and benefits with their obstetrician or GP and must not self-prescribe.

Elderly patients and people with liver disease may need dose adjustment, ECG monitoring and electrolyte checks before starting ondansetron.

• Absolute Contraindications: Known hypersensitivity to ondansetron; concomitant use with apomorphine.
• Caution Flags: Pre-existing QT prolongation, hypokalaemia, hypomagnesaemia, severe hepatic impairment, concurrent QT‑prolonging drugs.
• Monitoring Steps: Baseline ECG if cardiac history; check potassium and magnesium; review full medication list for serotonergic or QT‑prolonging drugs.

Q&A — Can I Drive After Taking It In The UK?

If ondansetron causes dizziness, fainting or drowsiness, do not drive or operate heavy machinery.

Contact your GP, pharmacist or the DVLA for guidance if you experience seizures, syncope or persistent drowsiness.

INN, UK Brand Names And Legal Classification

INN And Brands

Ondansetron is the International Nonproprietary Name (INN) for the drug commonly used to prevent nausea and vomiting.

Common UK brands include Zofran and generic ondansetron in film‑coated and orodispersible tablet forms.

• Common strengths: 4 mg, 8 mg.
• Common forms: Tablet, orodispersible tablet (ODT), intravenous solution.

Legal Classification (POM, P, GSL)

Ondansetron is classified as a Prescription‑Only Medicine (POM) in the UK and must be supplied on an NHS or private prescription.

NHS electronic prescriptions and private e‑prescriptions are accepted by community pharmacies and hospital supply chains.

INN:

Ondansetron.

Common Brand:

Zofran and generic ondansetron film‑coated or orodispersible tablets.

POM Status:

Prescription‑Only Medicine in the UK.

Standard Regimens And NHS Guidance

Standard Adult Dosing

Typical adult oral doses are 4 mg or 8 mg depending on indication.

Four milligram doses are frequently used for acute or post‑operative nausea and vomiting.

Eight milligram doses are commonly used in chemotherapy antiemesis and scheduled dosing may be required during treatment courses.

Intravenous equivalents are used in hospital for severe or immediate control.

Adjustments For Comorbidities

Dosing should be reduced or carefully monitored in hepatic impairment due to slower metabolism and increased exposure.

Correct hypokalaemia and hypomagnesaemia before administration and review concomitant QT‑prolonging drugs.

Q&A — What If I Miss A Dose?

For a single acute dose, take it as soon as you remember if still needed.

For scheduled courses, take the missed dose unless it is nearly time for the next dose; do not double up.

• Starting Checks: ECG where indicated, electrolytes, full drug review.
• Titration Notes: Use lowest effective dose and review necessity regularly for repeat prescriptions.

Food, Drink And Drug Interactions

Food And Beverages

There are no major food interactions with ondansetron, but alcohol can increase dizziness and worsen nausea.

Avoid excessive alcohol after post‑operative use while recovering.

Key Drug Conflicts And Yellow Card Highlights

Important interactions include other QT‑prolonging drugs such as some antiarrhythmics, certain antipsychotics and some macrolide antibiotics.

Concomitant serotonergic agents (SSRIs, SNRIs, MAOIs, triptans) raise the risk of serotonin syndrome.

Use with apomorphine is contraindicated.

Report suspected side effects to the MHRA Yellow Card scheme to help safety monitoring.

Interacting Drug Category	Clinical Risk	Management
QT‑Prolonging Drugs (e.g. certain antipsychotics, amiodarone)	Increased risk of torsades de pointes	Avoid combination or monitor ECG and electrolytes
Serotonergic Agents (SSRIs, SNRIs, triptans)	Serotonin syndrome	Review necessity, monitor for agitation, hyperreflexia, fever
Apomorphine	Severe hypotension and loss of consciousness	Contraindicated — do not co‑administer

Patient Experience: NHS Choices, Patient.info, Mumsnet Insights

Patients report rapid relief of nausea with ondansetron for chemotherapy and post‑operative causes in UK forums and NHS resources.

Commonly mentioned side effects are headache, constipation and occasional dizziness.

Orodispersible tablets are praised for ease of use, though some patients comment on taste.

• Effectiveness for severe nausea.
• Headaches reported by some users.
• Constipation as a possible side effect.
• Pregnancy and breastfeeding concerns.
• Accessibility and ODT taste/usability.

Clinicians are advised to triangulate forum reports with MHRA guidance and clinical trials when counselling patients.

Reported Outcome	Relative Frequency (Patient Resources)
Nausea Relief	Common
Headache	Occasional
Dizziness	Occasional

How UK Patients Obtain Ondansetron

High‑Street Pharmacies And Hospital Supply

Ondansetron is provided in hospitals for intravenous use and dispensed in community pharmacies on prescription.

Main chains such as Boots and LloydsPharmacy dispense prescriptions and hospital discharge packs may contain take‑home doses.

Online Pharmacies And NHS E‑Prescriptions

Patients can use NHS electronic prescriptions, private e‑prescriptions or reputable online pharmacies for collection or delivery.

Beware of overseas or illegal sellers and always check GPhC registration and NHS links when ordering online.

• Verify legitimate online pharmacies via NHS.uk links and GPhC registration.
• Ensure prescriber details are present and pharmacist counselling is available.

In our online pharmacy, ondansetron is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.

How Ondansetron Works (Plain English And Clinical Terms)

Simplified Explanation

Ondansetron blocks 5‑HT3 serotonin receptors in the gut and brainstem, reducing the nausea and vomiting signal to the brain.

This action is why ondansetron is effective for chemotherapy, radiotherapy and post‑operative nausea.

Clinical Pharmacology Terms

Onset of effect is typically within 30–60 minutes after oral dosing.

Plasma half‑life in adults is around 3–6 hours and the drug is predominantly metabolised by hepatic CYP enzymes.

5‑HT3 Antagonist

Blocks serotonin receptors involved in vomiting reflexes.

Chemoreceptor Trigger Zone

Brain area where ondansetron reduces emetic signalling.

QT Interval

Cardiac repolarisation measure; can be prolonged by ondansetron in high risk patients.

Metabolism

Primarily hepatic via CYP pathways with implications for liver impairment and interactions.

Approved Uses And NHS Practice

MHRA‑Approved Indications

Ondansetron is approved for prevention and treatment of chemotherapy‑, radiotherapy‑ and post‑operative nausea and vomiting.

Intravenous ondansetron is commonly used in hospitals for severe acute cases.

Off‑Label And Cautious Uses

Clinicians sometimes use ondansetron off‑label for refractory nausea from other causes when standard therapies fail.

Pregnancy use requires MHRA‑style benefit/risk assessment and often obstetrician input before prescribing.

• Approved: Chemotherapy, radiotherapy and post‑operative nausea and vomiting.
• Off‑Label: Refractory nausea from other causes — use with caution in pregnancy.

Major UK And EU Evidence (2022–2025 Overview)

Recent evidence continues to support ondansetron’s efficacy for chemotherapy and post‑operative antiemesis.

Safety reviews from 2022–2025 emphasise cardiac surveillance for QT prolongation and careful dose selection, particularly for ODTs and high‑risk patients.

Debates on maternal–fetal safety have prompted updated MHRA recommendations to individualise prescribing in pregnancy.

Study Type	Years	Main Findings	Clinical Implication
Randomised Controlled Trials	2022–2024	Confirmed efficacy for chemo/post‑op antiemesis	Supports standard dosing regimens
Observational Safety Studies	2023–2025	Highlighted QT risk in susceptible patients	Recommend ECG/electrolyte checks in at‑risk groups

Guidelines and local formularies should be consulted and care individualised for each patient.

NHS Prescribing Alternatives And Decision Checklist

Alternatives And Comparison

Alternative antiemetics on the NHS include cyclizine, prochlorperazine, metoclopramide and domperidone, each with different side‑effect profiles.

Choice depends on cause of nausea, patient comorbidities and cardiac history.

Drug	Typical Indication	Pros	Cons	Cardiac Risk
Cyclizine	Motion sickness, severe nausea	Effective for vestibular causes	Anticholinergic side effects	Low
Prochlorperazine	Acute severe nausea	Strong antiemetic effect	Extrapyramidal side effects	Moderate
Domperidone	Gastroparesis, nausea	Prokinetic effect	QT prolongation concerns	Higher — monitor ECG

Pros And Cons Checklist

• Confirm indication and likely cause of nausea.
• Review cardiac history and concomitant medications.
• Check pregnancy status and consult obstetrics where required.
• Decide on route of administration (oral vs IV) and patient preference.

Common Questions (Patient FAQs)

• Is Ondansetron Safe In Pregnancy? — Discuss with your obstetrician or GP; MHRA advises benefit versus risk assessment and specialist input where needed.
• How Quickly Does It Work? — Oral ondansetron often starts working within 30–60 minutes.
• Can Children Take It? — Paediatric dosing exists and must be prescribed by a paediatrician or GP; formulations include ODT and liquid in some settings.

For urgent concerns contact NHS 111, your GP or speak to a pharmacist for immediate advice.

Cost, Prescription Charging And Regional Differences

Prescription charging varies across the UK, with England generally charging per item unless exempt and Scotland, Wales and Northern Ireland providing prescriptions free at the point of dispensing for most patients.

Private prescription prices for ondansetron vary by pharmacy and formulation.

Source/Pharmacy	Typical Price Range (Private)	NHS Prescription Charge (England)	Exemption Status
Boots (Private)	Varies by formulation	£9.35 per item (England)	Exemptions apply (age, benefits, pregnancy)
LloydsPharmacy (Private)	Varies by formulation	£9.35 per item (England)	As above

Region	Prescription Charge
England	Per‑item charge (with exemptions)
Scotland	Generally free
Wales	Generally free
Northern Ireland	Generally free

Consider NHS prepayment certificates or exemption routes where applicable to reduce out‑of‑pocket costs.

MHRA Approval, NICE Guidance And Prescribing Framework

MHRA Processes And Safety Monitoring

The MHRA licences medicines, issues safety alerts and operates the Yellow Card scheme for adverse event reporting.

Report any suspected side effects via the Yellow Card to contribute to post‑marketing surveillance.

NHS Prescribing Framework

Hospital formularies guide IV ondansetron use, while primary care GPs prescribe oral courses for community treatment.

Specialist oncology teams manage antiemesis protocols for chemotherapy patients.

• Include indication, dose, route and duration on prescriptions.
• Document ECG history, pregnancy status and concomitant meds when relevant.

UK Household And Clinical Storage Advice

Household Storage (Cold/Damp Climate)

Store ondansetron at room temperature and protect it from moisture and light.

Keep the medicine in its original packaging and out of reach of children.

Dispose of unused tablets via pharmacy take‑back schemes.

Clinical Handling

Hospital IV preparations must be prepared aseptically and labelled according to pharmacy protocols.

Check expiry after reconstitution and follow local nursing guidelines for administration.

• For ODTs: keep blister intact until use and place on the tongue to dissolve.
• For travel: carry a copy of your prescription and store below 25°C where possible.

Pharmacist Counselling Style And NHS Patient Safety Advice

Counselling Checklist For UK Pharmacists

• Confirm the indication and check for allergies.
• Ask about pregnancy, breastfeeding and childbearing potential.
• Review the full medication list, especially QT‑prolonging and serotonergic drugs.
• Explain dosing, timing and possible side effects such as headache and constipation.
• Advise on driving and when to seek urgent care: chest pain, palpitations, fainting, seizures or severe allergic reaction.

Practical Patient Safety Measures

Provide a written action plan for post‑op or chemotherapy antiemesis and suggest a medication card listing allergies and ECG‑relevant history.

Encourage patients to report adverse effects to the MHRA Yellow Card scheme and to follow up with their GP.

Delivery Across United Kingdom

City	Region	Delivery time
London	England	5-7 days
Manchester	England	5-7 days
Birmingham	England	5-7 days
Glasgow	Scotland	5-7 days
Edinburgh	Scotland	5-7 days
Leeds	England	5-7 days
Liverpool	England	5-7 days
Bristol	England	5-7 days
Newcastle	England	5-9 days
Aberdeen	Scotland	5-9 days
Plymouth	England	5-9 days
Swansea	Wales	5-9 days
Inverness	Scotland	5-9 days